Patents by Inventor Martin JARMAN

Martin JARMAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11090116
    Abstract: An electrosurgical waveform having both radiofrequency (RF) energy and microwave energy components that is arranged to perform efficient haemostasis in biological tissue. The waveform comprises a first portion primarily of RF electromagnetic energy, and a second portion primarily of microwave electromagnetic energy that follows the first portion. The second portion further comprises a plurality of RF pulses, wherein the first portion transitions to the second portion when either a duration of the first portion meets or exceeds a predetermined duration threshold, or an impedance determined during the first portion meets or exceeds a predetermined threshold. The waveform is arranged to deliver energy rapidly so that haemostasis can occur in a short time frame in a situation where the maximum available power is limited, or to avoid undesirable thermal damage to the biological tissue.
    Type: Grant
    Filed: May 19, 2017
    Date of Patent: August 17, 2021
    Assignee: CREO MEDICAL LIMITED
    Inventors: Christopher Paul Hancock, Francis Amoah, Martin Jarman
  • Patent number: 10426542
    Abstract: A pulsed RF cut waveform profile for electrosurgery, in which each pulse is formed of a composite of different pulse portions. The pulse includes a controllable treatment portion whose duration can be truncated as necessary to ensure that the average power delivered by the pulse as a whole does not exceed a predetermined value. A limit for the average power delivered by the composite pulse (i.e. total energy delivered over the duration of the ON and OFF portions divided by the pulse duration) may be selectable by the operator. The ON portion may have multiple sub-portions, which have different purposes. Each pulse may be automatically controlled for pulse width in this manner, so that the RF signal effectively responds intelligently to conditions at the probe tip during treatment.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: October 1, 2019
    Assignee: CREO MEDICAL LIMITED
    Inventors: Francis Amoah, Christopher Paul Hancock, Martin Jarman, Nuwan Dharmisiri
  • Patent number: 10299850
    Abstract: A method of controlling RF power delivered from a bipolar electrosurgical instrument into a biological tissue. The method comprises controlling the profile of a RF waveform by: setting a maximum voltage limit for a voltage applied across the bipolar electrosurgical instrument; calculating a tissue resistance, the calculating step including a correction for an impedance associated with the RF channel; determining an objective tissue current limit from the calculated tissue resistance and a predetermined power dissipation target; and dynamically adjusting the current limit based on the determined objective tissue current limit. This control method may ameliorate the impact of an increased cable length on the accuracy of control of RF waveforms delivered to the tip of the probe.
    Type: Grant
    Filed: April 14, 2014
    Date of Patent: May 28, 2019
    Assignee: CREO MEDICAL LIMITED
    Inventors: Francis Amoah, Christopher Paul Hancock, Martin Jarman, Nuwan Dharmisiri
  • Publication number: 20190125442
    Abstract: An electrosurgical waveform having both radiofrequency (RF) energy and microwave energy components that is arranged to perform efficient haemostasis in biological tissue. The waveform comprises a first portion primarily of RF electromagnetic energy, and a second portion primarily of microwave electromagnetic energy that follows the first portion. The second portion further comprises a plurality of RF pulses, wherein the first portion transitions to the second portion when either a duration of the first portion meets or exceeds a predetermined duration threshold, or an impedance determined during the first portion meets or exceeds a predetermined threshold. The waveform is arranged to deliver energy rapidly so that haemostasis can occur in a short time frame in a situation where the maximum available power is limited, or to avoid undesirable thermal damage to the biological tissue.
    Type: Application
    Filed: May 19, 2017
    Publication date: May 2, 2019
    Inventors: Christopher Paul HANCOCK, Francis AMOAH, Martin JARMAN
  • Publication number: 20160120588
    Abstract: A pulsed RF cut waveform profile for electrosurgery, in which each pulse is formed of a composite of different pulse portions. The pulse includes a controllable treatment portion whose duration can be truncated as necessary to ensure that the average power delivered by the pulse as a whole does not exceed a predetermined value. A limit for the average power delivered by the composite pulse (i.e. total energy delivered over the duration of the ON and OFF portions divided by the pulse duration) may be selectable by the operator. The ON portion may have multiple sub-portions, which have different purposes. Each pulse may be automatically controlled for pulse width in this manner, so that the RF signal effectively responds intelligently to conditions at the probe tip during treatment.
    Type: Application
    Filed: April 14, 2014
    Publication date: May 5, 2016
    Applicant: CREO MEDICAL LIMITED
    Inventors: Francis AMOAH, Christopher Paul HANCOCK, Martin JARMAN, Nuwan DHARMISIRI
  • Publication number: 20160074091
    Abstract: A method of controlling RF power delivered from a bipolar electrosurgical instrument into a biological tissue. The method comprises controlling the profile of a RF waveform by: setting a maximum voltage limit for a voltage applied across the bipolar electrosurgical instrument; calculating a tissue resistance, the calculating step including a correction for an impedance associated with the RF channel; determining an objective tissue current limit from the calculated tissue resistance and a predetermined power dissipation target; and dynamically adjusting the current limit based on the determined objective tissue current limit. This control method may ameliorate the impact of an increased cable length on the accuracy of control of RF waveforms delivered to the tip of the probe.
    Type: Application
    Filed: April 14, 2014
    Publication date: March 17, 2016
    Inventors: Francis AMOAH, Christopher Paul HANCOCK, Martin JARMAN, Nuwan DHARMISIRI